Landmark CLEAR Outcomes Study Demonstrates NEXLETOL (bempedoic acid) Tablet is the Only LDL-C Lowering Therapy Since Statins to Reduce Hard Ischemic Events in a Broad Population | DAIC
These highlights do not include all the information needed to use NEXLETOL® safely and effectively. See full prescribing information for NEXLETOL. NEXLETOL (bempedoic acid) tablets, for oral use Initial U.S. Approval: 2020
Statin alternatives Nilemdo and Nustendi supplied via Alliance only :: C+D
Role of Bempedoic Acid in Clinical Practice | SpringerLink